FOLD - Amicus Therapeutics Inc.'s (FOLD) CEO John Crowley on Q1 2022 Results - Earnings Call Transcript
Amicus Therapeutics, Inc. (FOLD) Q1 2022 Earnings Conference Call May 09, 2022, 08:30 AM ET Company Participants Andrew Faughnan - Executive Director-Investor Relations John Crowley - Chairman and Chief Executive Officer Bradley Campbell - President and Chief Operating Officer Daphne Quimi - Chief Financial Officer Jeffrey Castelli - Chief Development Officer Conference Call Participants Ritu Baral - Cowen Anupam Rama - JPMorgan Ellie Merle - UBS Beth Feindt-Scott - SVB Leerink Kristen Kluska - Cantor Fitzgerald Dae Gon Ha - Stifel Salveen Richter - Goldman Sachs Yun Zhong - BTIG Presentation Operator Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics’ First Quarter 2022 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now
For further details see:
Amicus Therapeutics, Inc.'s (FOLD) CEO John Crowley on Q1 2022 Results - Earnings Call Transcript